need, announced that it will be issued U.S. Patent No. 12,410,418 by the U.S. Patent and Trademark Office on September 9, 2025, titled “Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B Virus...
and approved by leading global regulatory agencies including the USFDA, PMDA (Japan), and CDSCO (India). As of March 2025, Sai Life Sciences’ manufacturing units had undergone over 75 customer audits in the past three years, reflecting its...
virkningsmekanisme. Studiet forventes at inkludere 32 patienter, hvor den første patient forventes inkluderet i 4. kvartal 2025. ”Myndighedsgodkendelsen af vores RNX-011-studie er en afgørende kommerciel milepæl for Pharma Equity Group. Vi tager nu...
FIP world congress 2025, themed “Pharmacy Forward: Performance, Collaboration, and Health Transformation,” aims to explore the evolving role of the pharmacy profession in the context of modern healthcare challenges. FIP world congress 2025, themed...
In the IIT, the patient began with a baseline hemoglobin level of 67.3 g/L. Following CS-101 treatment in February 2025, she achieved rapid hematopoietic recovery, with neutrophil engraftment in 13 days and platelet counts surpassing 50×10⁹/L in 21...
the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces its 2025 interim results and major business updates. Dr. Michael Yu, Founder, Chairman of the Board and CEO of Innovent, stated:...
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected pharmaceutical manufacturing shows in Singapore for pharmaceutical and biomanufacturing professionals. The ISPE Singapore Affiliate Conference &...
Breakthrough Data Validates its Dual-immune Activation Mechanism, Stepwise Development in Multiple Tumor Types: At ASCO 2025, Phase 1b/2 results demonstrated meaningful and durable clinical activity in areas of high unmet need, including...
13th World Conference on Pharmaceutical Science and Drug Manufacturing (WCPD) 2025 hosted by IFERP Life Sciences will offer a diverse range of topics, from drug discovery and development to clinical trials, applications and healthcare delivery....
rhCollagen for tissue regeneration and medical aesthetics, announced financial results for the second quarter of 2025 and provided a corporate update. Yehiel Tal, CollPlant's Chief Executive Officer commented, "In recent months, CollPlant has been...
by the National Emergency Operation Center (NEOC) Afghanistan, UNICEF, WHO, and other GPEI partners starting in August 2025. Focused on the Eastern region of Afghanistan, the campaign will deploy Tropis ID to administer 1.3 million fractional doses...
any artificial additives. The results of this study—drawn from a double-blind national survey of U.S. pediatricians (FRC 2025) — found that an overwhelming majority of respondents prefer Genexa’s oral suspension ingredient profiles for treating...
upon commercial marketing of the medicine. Venofer® had annual sales of approximately $515M in the U.S. as of June 30, 2025, according to IQVIA. Iron Sucrose Injection, For Intravenous Use INDICATION AND USAGE Iron sucrose injection is indicated...
following radiotherapy.6 Modeyso was developed by Chimerix prior to its acquisition by Jazz Pharmaceuticals in April 2025. DRUG INTERACTIONS Strong and Moderate CYP3A4 Inhibitors Avoid concomitant use of MODEYSO with strong and moderate CYP3A4...
USP in the United States as a therapeutic generic equivalent of Ablysinol®, which ended its market exclusivity in June 2025. Dehydrated Alcohol Injection is indicated to induce controlled cardiac septal infarction to improve exercise capacity in...
marks our fifth product launch this year, expanding our portfolio to twenty-five products with several more planned for 2025 and beyond," said Vimal Kavuru, Chairman & CEO. This launch enhances Cronus Pharma's robust sedative and anesthesia product...
of Australia (MTAA) are excited to collaborate for the first time to jointly produce Australia Regulatory Device Summit 2025, convening 17-18 July at ICC Sydney in Sydney, Australia. This two-day event will unite experts from Therapeutic Goods...
strategy leveraging TrueMed's digital authentication technology to identify and act on threats instantly. "You can't fight 2025 counterfeits with 2010 tools," said Jyrki Berg, CEO of TrueMed. "Our collaboration with Alliance Pharmaceuticals Ltd...
novel EGFR/HER3 bispecific antibody-drug conjugate (ADC), in patients with advanced solid tumors. On January 7th, 2025, DualityBio and Avenzo announced that they have entered into an exclusive license agreement, pursuant to which Avenzo will...
said Dr. Stephanie Venn-Watson, Co-CEO of Seraphina Therapeutics. Dr. Venn-Watson was recently recognized as a 2025 CNBC Changemaker for her research on C15:0's essentiality and the discovery of Cellular Fragility Syndrome. In 2020, C15:0...
